Clinic
Pipeline East Dallas, LLC
Pipeline East Dallas, LLC was paid $4.86M by Medicaid between Aug 2019 and Dec 2024, across 84 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoPIPELINE EAST DALLAS, LLC
DALLAS, TX 75218
DALLAS, TX 75218
33aNPI1083112023assigned 01/24/2018
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$4.86M
24GClaims123,932
24DCodes billed84
24AFirst – last monthAug 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#81 of 320
Median peer was paid$205K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 271 | $16K | |
| 2020 | 6,099 | $237K | |
| 2021 | 34,300 | $944K | |
| 2022 | 43,038 | $1.79M | |
| 2023 | 33,173 | $1.64M | |
| 2024incomplete | 7,051 | $233K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 7,074 | 6,575 | $1.36M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 11,674 | 11,094 | $1.35M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 4,385 | 3,915 | $848K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 1,639 | 1,545 | $122K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 3,019 | 2,595 | $119K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 10,128 | 5,599 | $110K |
| 80053 | Comprehensive metabolic panel | 2.0% | 8,234 | 7,130 | $97K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 4,526 | 4,048 | $95K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 346 | 307 | $84K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 888 | 783 | $69K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 5,145 | 4,905 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 9,158 | 7,837 | $52K |
72 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 1,141 | $49K |
| 81025 | <1% | 4,240 | $42K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,887 | $37K |
| 83880 | <1% | 1,617 | $37K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,756 | $34K |
| 84484 | <1% | 3,359 | $29K | |
| 83690 | <1% | 4,238 | $27K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 861 | $23K |
| 81001 | <1% | 6,001 | $22K | |
| G0378 | Hospital observation service, per hour | <1% | 156 | $19K |
| 87088 | <1% | 2,487 | $14K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,804 | $14K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 55 | $11K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 770 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,450 | $10K |
| 87081 | <1% | 1,198 | $10K | |
| 76801 | <1% | 84 | $9K | |
| 59025 | Fetal non-stress test | <1% | 258 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 203 | $9K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 695 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,118 | $8K |
| 83605 | <1% | 1,032 | $7K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 714 | $6K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 195 | $6K |
| 85730 | <1% | 1,252 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 806 | $3K |
| 85610 | <1% | 1,351 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 383 | $3K |
| 83735 | <1% | 604 | $3K | |
| 82550 | <1% | 661 | $3K | |
| 84702 | <1% | 186 | $2K | |
| 87807 | <1% | 258 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 195 | $2K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 110 | $2K |
| J3490 | Unclassified drugs | <1% | 2,360 | $2K |
| 81003 | <1% | 991 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 110 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 330 | $1K |
| 87186 | <1% | 177 | $985.64 | |
| 87040 | <1% | 110 | $963.73 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 349 | $906.11 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 746 | $888.19 |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,667 | $782.42 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 40 | $661.55 |
| 86900 | <1% | 268 | $637.39 | |
| 86901 | <1% | 252 | $600.19 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 24 | $545.25 |
| 99001 | <1% | 25 | $487.80 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 15 | $288.09 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 31 | $281.85 |
| 84145 | <1% | 13 | $279.38 | |
| 86850 | <1% | 19 | $214.69 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 38 | $170.05 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 33 | $162.99 |
| A9150 | Non-prescription drugs | <1% | 194 | $134.91 |
| 87077 | <1% | 18 | $126.26 | |
| 85379 | <1% | 17 | $116.94 | |
| 85027 | <1% | 36 | $86.78 | |
| 36000 | <1% | 14 | $77.16 | |
| 81002 | <1% | 44 | $62.32 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $22.10 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 253 | $15.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 21 | $13.79 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 921 | $12.64 |
| 82962 | <1% | 1,191 | $2.53 | |
| A9270 | Non-covered item or service | 0% | 147 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 27 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 38 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 36416 | 0% | 14 | $0.00 | |
| 85008 | 0% | 12 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARKAAT, SYED (COO)
| Provider | Location | Paid |
|---|---|---|
| North Houston Surgical Hospital, LLC | Spring, TX | $16K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.